Canada approves Moderna's RSV vaccine for adults aged 60 and older
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
AstraZeneca’s Tezspire Shows Promise in Phase III Trial
AstraZeneca (GB:AZN) has released an update. AstraZeneca’s Tezspire has shown promising results in the Phase III WAYPOINT trial, ...
FiercePharma3d
Fierce Pharma Asia—AstraZeneca's China fallout; Pfizer's $1B plan in China; Incyte-Sun JAK dispute
AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...
Hosted on MSN4d
Indian 'vaccine prince' becomes owner of 'London's most expensive home' this year after paying £138million for Mayfair mansion
In 2021, the family pledged £50million to Oxford university for a new Poonawalla Vaccines Research Building, having manufactured hundreds of millions of doses of the Oxford/AstraZeneca vaccine.
Business Insider6d
BioVaxys Joins US Vaccine Development Consortium
This strategic move positions BioVaxys alongside major players like AstraZeneca and Genentech, enhancing its role in developing priority vaccine programs. For further insights into TSE:BIOV stock, ...